scorecardresearch
Thursday, October 31, 2024
TopicFDA

Topic: FDA

1st US FDA-approved drug invented in India set for local launch as part of combination antibiotic

Combination of enmetazobactam, invented by scientists associated with Chennai-based pharma firm Orchid Pharma in 2008, and antibiotic cefipime is used to treat severe bacterial infection.

‘Ban McDonald’s nationwide,’ says traders’ body after ‘fake cheese’ found in burger in Maharashtra

Such fraudulent practices cannot be tolerated, CAIT adds. This comes after Food & Drug Administration allegedly found counterfeit cheese at fast food giant's outlet in Ahmednagar.

US cracks down on healthcare product makers following cough syrup deaths overseas

Cough syrups made in India & Indonesia have been linked to deaths of over 300 children globally. Medicines were found to contain high levels of DEG, EG, leading to death.

Op Broader Sword: India, US join hands to crack down on shipments of ‘illicit’ drugs, medical devices

Operation targeted packages entering US from India through New York (JFK) & Chicago (ORD) International Mail Facilities (IMFs) last month. Over 500 shipments seized, Indian national held.

After Singapore, US now approves sale of lab-grown meat in restaurants, grocery stores

The US government’s approval to two California-based companies is being seen as a huge step for the alternative protein industry.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

US FDA takes new dengue vaccine by Japanese firm Takeda for priority review

Takeda has carried out phase 3 trials of the vaccine candidate and found it to be 80.2% effective in preventing symptomatic dengue cases after a year of vaccination.

‘No prescription sought, drugs under different names’ — Maharashtra FDA busts ‘abortion pill racket’

FDA officers in 13 parts of the state posed as customers and managed to easily procure the kits. FIRs lodged against e-commerce app, ‘unlicensed’ agency.

US rejection of emergency use for Covaxin will not impact India’s vaccination drive: Govt

NITI Aayog member V K Paul said that he respected US' decision and hoped that the vaccine manufacturer will comply with the parameters of their regulatory system.

US FDA approves first new Alzheimer’s drug in 20 years despite warnings from experts

The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, but only slowed it in one study. The drug is given as an infusion every four weeks.

On Camera

Hyderabad has a HYDRAA-headed bulldozer story. Saving lakes or razing opposition?

Revanth Reddy’s bulldozing of lake ‘encroachments’ with new agency HYDRAA have left some serious questions unanswered, especially regarding the selective nature of the work undertaken.

iPhone craze, Goa trips, to making ends meet, ‘addictive’ instant loan apps leading many into debt trap

Unsecured loans have been a concern for RBI for a while now. Last year, it took steps to make it more expensive for banks, NBFCs to give them out in bid to deter such borrowing.

India-China disengagement completed at Depsang & Demchok, patrolling to start after Diwali

Corps commanders signed an agreement on 21 October to pull back troops from eastern Ladakh’s two face-off points, following efforts on diplomatic front to ease tensions along LAC.

From 2004 to 2024, bad news has come wrapped as good news for Congress

Congress is silently acknowledging it over-read verdict of last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand.